TLR2 and acute myeloid leukemia: In acute myeloid leukemia (AML), tumor-derived extracellular vesicles (EVs) activate TLR2 signaling on monocytes via their surface palmitoylated proteins, inducing their differentiation into immunosuppressive CD14+HLA-DRlow MDSCs.